NOT-CA-21-035: Notice of Change to Key Dates in RFA-CA-21-001, "Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)"

Notice of Change to Key Dates in RFA-CA-21-001, "Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)"

Notice Number:

NOT-CA-21-035

Key Dates

Release Date:

February 18, 2021

RFA-CA-21-001 - Small Business Transition Grant for Early Career Scientists (R42 Clinical Trial Not Allowed)

National Cancer Institute (NCI)

The purpose of this Notice is to revise the “Key Dates” for RFA-CA-21-001.

I. Part 1 Key Dates in RFA-CA-21-001 Currently Reads:

Application Due Date(s)

March 10, 2020. All applications are due by 5:00 PM local time of the applicant organization.

Scientific Merit Review

June/July 2021

Advisory Council Review

August 2021

Earliest Start Date

September 1, 2021

Expiration Date

March 11, 2021

II. Part 1 Key Dates in RFA-CA-21-001 Modified (by this Notice) to Read (in italics):

Application Due Date(s)

March 24, 2021. All applications are due by 5:00 PM local time of the applicant organization.

Scientific Merit Review

June/July 2021

Advisory Council Review

August 2021

Earliest Start Date

September 1, 2021

Expiration Date

March 25, 2021

Note: All other aspects of RFA-CA-21-001 remain unchanged.

Please direct all inquiries to:

Kory Hallett, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5882
Email: [email protected]